Home

Roy D. Baynes, Director: Travere Therapeutics TVTX Sell · Filed 05/06

Trade details

Type
Insider sale
Amount
$209,925
Shares · price
4,500 sh · $46.65 a share
Held after
37,500 sh
Trade date
26/05/05
Filed
26/05/06
Days to filing
1 days

Sold 10.7% of holdings

Share of holding sold
10.7%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 04/05~06/04

Roy D. Baynes's recent trades

  • Roy D. Baynes

    Sell10b5-1 planTravere Therapeutics

    $225K

    Filed 06/16

  • Roy D. Baynes

    Planned sale10b5-1 planTravere Therapeutics

    $225K

    Filed 06/12

  • Roy D. Baynes

    Planned sale10b5-1 planTravere Therapeutics

    $209.9K

    Filed 05/05

  • Roy D. Baynes

    Sell10b5-1 planTravere Therapeutics

    $431.1K

    Filed 05/04

  • Roy D. Baynes

    Planned sale10b5-1 planTravere Therapeutics

    $431.1K

    Filed 05/01